Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06697314 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System

Study acronym: RECOVER-AV
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Enrollment target: 366 to 256
    • Start date changed from estimate of Jan 2025 to Jun 15, 2025
    • Study sites: 0 to 1
    • Primary and study completion dates: Jan 2028 to Jun 2028
    • Secondary endpoints: 23 to 22
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the efficacy, safety, and long-term functional outcomes of percutaneous mechanical aspiration thrombectomy using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System for the treatment of acute pulmonary embolism.
Trial Details
NCT Number NCT06697314
Lead Sponsor Angiodynamics, Inc.
Conditions
(from sponsor)		 Acute Pulmonary Embolism (PE), Pulmonary Embolism
Related terms Pulmonary Embolism
Enrollment 256 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov